Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling PLoS One. 2018 Apr 3;13(4):e0195401. doi: 10.1371/journal.pone.0195401.
Authors
Luchsinger C, Aguilar M, Burgos PV, Ehrenfeld P, Mardones GA (2018)